Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford Cancer Institute, posted on X:
“Another landmark day for solid tumor cell therapy at Stanford Cancer Institute with our first infusion of FDA approved afami-cel (Tecelra), an engineered TCR T cell therapy for synovial sarcoma. We are thrilled to make this available to our patients!!”